Evidence-backed therapies—from next-generation medications to trusted prescription drugs—designed to help you achieve sustainable weight loss.
All treatments on this page are supported by peer-reviewed clinical trials showing real, statistically significant weight loss for people struggling to reduce excess weight.
Medications require supervision and a tailored plan by a healthcare provider—ensuring the safest, most effective treatment for your unique medical history.
Choose from multiple drug classes—GLP-1 agonists, appetite suppressants, newer injectables—matched to your lifestyle, health risks, and weight loss goals.
Modern obesity medications don't just target the scale—they reduce the risk of diabetes, heart disease, and other complications linked to excess body weight.
Obesity is a chronic, relapsing condition—impacted by biology, environment, and behavior. For many, lifestyle changes alone are not enough. Today, specialized medications are shifting what’s possible, allowing people to lose clinically meaningful weight, keep it off, and improve metabolic health.
This guide covers the main categories of FDA-approved medical treatments, the science behind each, and how to work with a provider to choose the right protocol. See our full weight loss medications resource for additional comparisons.
Originally developed for diabetes, GLP-1 receptor agonists mimic a hormone that signals fullness and regulates blood sugar. Today, drugs like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) are first-line medical treatments for obesity. Injected weekly or daily, patients in clinical trials lose 15–22% of body weight on average—significantly more than with older pills.
Before injectables, pills like phentermine/topiramate (Qsymia), naltrexone/bupropion (Contrave), and orlistat (Alli, Xenical) represented standard medical options. These drugs reduce appetite, alter cravings, or block fat absorption. Typical weight loss is more modest—about 5–10% of body weight—but effects are proven and side effects tend to be manageable with monitoring.
Tirzepatide is a breakthrough "twincretin"—stimulating both GLP-1 and GIP receptors for even more robust metabolic effects. In head-to-head studies, it leads to the highest average weight loss of any approved obesity drug, with many patients reaching or surpassing 20% body weight reduction. It is injected once weekly and is safe for most, but requires physician guidance.
Liraglutide preceded semaglutide as a once-daily injectable GLP-1 agonist for weight management. It remains an important option—especially for individuals preferring daily dosing, or who do not tolerate newer weekly drugs. Weight loss results average 8–12% of body weight in major trials.
While medical therapy can deliver results far beyond diet and exercise alone, the most successful outcomes involve a comprehensive plan. Behavioral support, nutrition counseling, and activity tracking help sustain weight loss and build healthy habits. Medication creates new possibilities, but commitment and follow-up are essential for long-term success.
Treatment is typically considered for adults with a body mass index (BMI) of 30 or higher, or 27+ with an obesity-related health problem such as high blood pressure, sleep apnea, or prediabetes. Your provider will assess your history, current medications, and risk factors to determine the safest options. More on obesity medications
Access to modern obesity medications is improving but can be affected by insurance coverage and cost. Many brand-name injectables are expensive without insurance, but assistance programs or patient copay cards are often available. Discuss all options—including traditional oral medications—if cost is a concern.
For a side-by-side comparison of all approved drugs, visit our weight loss drugs overview.